AAAAAA
Results:
1-25
|
Results: 25
Authors:
Song, RXD
Mor, G
Naftolin, F
McPherson, RA
Song, J
Zhang, ZG
Yue, W
Wang, JP
Santen, RJ
Citation: Rxd. Song et al., Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17 beta-estradiol, J NAT CANC, 93(22), 2001, pp. 1714-1723
Authors:
Seli, E
Selam, B
Mor, G
Kayisli, UA
Pehlivan, T
Arici, A
Citation: E. Seli et al., Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect, MENOPAUSE, 8(4), 2001, pp. 296-301
Authors:
Mor, G
Munoz, A
Redlinger, R
Silva, I
Song, J
Lim, C
Kohen, F
Citation: G. Mor et al., The role of the Fas/Fas ligand system in estrogen-induced thymic alteration, AM J REPROD, 46(4), 2001, pp. 298-307
Authors:
Silva, I
Mor, G
Naftolin, F
Citation: I. Silva et al., Estrogen and the aging brain, MATURITAS, 38(1), 2001, pp. 95-100
Authors:
Hsu, CD
Harirah, H
Basherra, H
Mor, G
Citation: Cd. Hsu et al., Serum soluble Fas levels in preeclampsia, OBSTET GYN, 97(4), 2001, pp. 530-532
Authors:
Mor, G
Kohen, F
Garcia-Velasco, J
Nilsen, J
Brown, W
Song, J
Naftolin, F
Citation: G. Mor et al., Regulation of Fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen, J STEROID B, 73(5), 2000, pp. 185-194
Authors:
Bechmann, I
Lossau, S
Steiner, B
Mor, G
Gimsa, U
Nitsch, R
Citation: I. Bechmann et al., Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterogradedegeneration, GLIA, 32(1), 2000, pp. 25-41
Authors:
Ben-Hur, H
Gurevich, P
Ben-Arie, A
Huszar, M
Berman, V
Tendler, Y
Tchanishev, R
Mor, G
Gershon, S
Zusman, I
Citation: H. Ben-hur et al., Apoptosis and apoptosis-related proteins (Fas, Fas ligand, bcl-2, p53) in macrophages of human ovarian epithelial tumors, EUR J GYN O, 21(2), 2000, pp. 141-145
Authors:
Ben-Hur, H
Gurevich, P
Huszar, M
Ben-Arie, A
Berman, V
Tendler, Y
Zinder, O
Tchanishev, R
Gershon, S
Mor, G
Zaltsman, Y
Kohen, F
Zusman, I
Citation: H. Ben-hur et al., Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors, EUR J GYN O, 21(1), 2000, pp. 53-57
Authors:
Rutherford, T
Brown, WD
Sapi, E
Aschkenazi, S
Munoz, A
Mor, G
Citation: T. Rutherford et al., Absence of estrogen receptor-beta expression in metastatic ovarian cancer, OBSTET GYN, 96(3), 2000, pp. 417-421
Authors:
Nilsen, J
Mor, G
Naftolin, F
Citation: J. Nilsen et al., Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system, J NEUROBIOL, 43(1), 2000, pp. 64-78
Authors:
Song, J
Sapi, E
Brown, W
Nilsen, J
Tartaro, K
Kacinski, BM
Craft, J
Naftolin, F
Mor, G
Citation: J. Song et al., Roles of Fas and Fas ligand during mammary gland remodeling, J CLIN INV, 106(10), 2000, pp. 1209-1220
Authors:
Mor, G
Eliza, M
Citation: G. Mor et M. Eliza, DNA vaccination - Tolerance and autoimmunity, METH MOL M, 29, 2000, pp. 489-497
Authors:
Senturk, LM
Seli, E
Gutierrez, LS
Mor, G
Zeyneloglu, HB
Arici, A
Citation: Lm. Senturk et al., Monocyte chemotactic protein-1 expression in human corpus luteum, MOL HUM REP, 5(8), 1999, pp. 697-702
Authors:
Garcia-Velasco, JA
Arici, A
Zreik, T
Naftolin, F
Mor, G
Citation: Ja. Garcia-velasco et al., Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis, MOL HUM REP, 5(7), 1999, pp. 642-650
Authors:
Santen, RJ
Yue, W
Naftolin, F
Mor, G
Berstein, L
Citation: Rj. Santen et al., The potential of aromatase inhibitors in breast cancer prevention, ENDOCR-R CA, 6(2), 1999, pp. 235-243
Authors:
Diano, S
Horvath, TL
Mor, G
Register, T
Adams, M
Harada, N
Naftolin, F
Citation: S. Diano et al., Aromatase and estrogen receptor immunoreactivity in the coronary arteries of monkeys and human subjects, MENOPAUSE, 6(1), 1999, pp. 21-28
Authors:
Bechmann, I
Mor, G
Nilsen, J
Eliza, R
Nitsch, R
Naftolin, F
Citation: I. Bechmann et al., FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier, GLIA, 27(1), 1999, pp. 62-74
Authors:
Ben-Hur, H
Gurevich, P
Huszar, M
Ben-Arie, A
Berman, V
Tendler, Y
Tchanishev, R
Zinder, O
Mor, G
Zaltsman, Y
Kohen, F
Zusman, I
Citation: H. Ben-hur et al., Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: immunohistochemical and morphometric studies, EUR J GYN O, 20(4), 1999, pp. 249-253
Authors:
Gutierrez, LS
Eliza, M
Niven-Fairchild, T
Naftolin, F
Mor, G
Citation: Ls. Gutierrez et al., The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas, BREAST CANC, 54(3), 1999, pp. 245-253
Authors:
Mor, G
Nilsen, J
Horvath, T
Bechmann, I
Brown, S
Garcia-Segura, LM
Naftolin, F
Citation: G. Mor et al., Estrogen and microglia: A regulatory system that affects the brain, J NEUROBIOL, 40(4), 1999, pp. 484-496
Authors:
Ichino, M
Mor, G
Conover, J
Weiss, WR
Takeno, M
Ishii, KJ
Klinman, DM
Citation: M. Ichino et al., Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine. (vol 162, pg 3814, 1999), J IMMUNOL, 163(2), 1999, pp. 1094-1094
Authors:
Ichino, M
Mor, G
Conover, J
Weiss, WR
Takeno, M
Ishii, KJ
Klinman, DM
Citation: M. Ichino et al., Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine, J IMMUNOL, 162(7), 1999, pp. 3814-3818
Authors:
Nilsen, J
Mor, G
Naftolin, F
Citation: J. Nilsen et al., Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells, MENOPAUSE, 5(4), 1998, pp. 211-216
Authors:
Mor, G
Yue, W
Santen, RJ
Gutierrez, L
Eliza, M
Berstein, LM
Harada, N
Wang, JP
Lysiak, J
Diano, S
Naftolin, F
Citation: G. Mor et al., Macrophages, estrogen and the microenvironment of breast cancer, J STEROID B, 67(5-6), 1998, pp. 403-411
Risultati:
1-25
|